Hospital for Special Surgery
New York, 10021, United States
Location status: Recruiting
Location contact
Eliza Pelrine, BA
CONTACT
Jessica Gordon, MD
SUB_INVESTIGATOR
Robert Spiera, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT01656447
The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.
Interested in participating?
Request Info18 year and older
All sexes
Observational
New York, 10021, United States
Location status: Recruiting
Eliza Pelrine, BA
CONTACT
Jessica Gordon, MD
SUB_INVESTIGATOR
Robert Spiera, MD
PRINCIPAL_INVESTIGATOR
What will be asked of you:
Benefits to Patients:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline & follow-up visits during regularly scheduled appointments for up to 5 years
Physician score of skin thickening over 17 areas of the body.
Time frame: Baseline & follow-up visits during regularly scheduled appointments for up to 5 years
Patient questionnaire
Time frame: Baseline & follow-up visits during regularly scheduled appointments for up to 5 years
Patient questionnaire
Contact information is provided by the study sponsor or research team.
Eliza Pelrine, BA
CONTACT
Emily Bakaj, BA
CONTACT
Hospital for Special Surgery, New York
Other
The Scleroderma Registry & Repository
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06328777
Autoimmune Diseases, Connective Tissue Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT05098704
Connective Tissue Diseases, Scleroderma
Bayonne, France
View Trial DetailsNCT07641634
Connective Tissue Diseases, Healthy Volunteers
Melbourne, Victoria, Australia
View Trial DetailsNCT06991114
Arthritis, Arthritis, Rheumatoid
Tuscaloosa, Alabama, United States
View Trial Details